PLEASE READ — ABH PHARMA, INC.; ABH NATURE’S PRODUCTS; AND STOCKNUTRA.COM INC. FDA RECALL IMPACTING BIOREBALANCE PRODUCTS
February 14, 2020
At BioRebalance, we appreciate you as a loyal customer and value your continued trust above all else. As such, we would like to notify you of a recall that was initiated regarding a manufacturer that produced our first round of production, ABH Pharma, Inc. It has come to our attention that ABH Pharma failed to meet certain FDA requirements, and as a result, has issued a nationwide recall of all the products that were made at its facility, including the first round of production for BioRebalance, as well as many other products made for over 800 individual companies or brands.
You can read ABH Pharma’s public announcement regarding its FDA recall by clicking here.
We’ve been assured by the manufacturer that there have been NO reported illnesses or injuries at this time. We have also not received any health-related complaints concerning the products that ABH manufactured on our behalf.
However, out of an abundance of caution, we are asking any customers that have any bottles of BioRebalance to discontinue use immediately. The specific product information is below:
Please examine the product you may have received from us to determine if it is subject to ABH’s recall. If the product is subject to the recall, please contact us at [email protected].
Please rest assured that we no longer conduct any business with ABH and have identified a new manufacturer to source and produce products to our exacting standards in order to ensure that our customers continue to receive and benefit from BioRebalance quality supplements.
Our second round of production with our new manufacturing partner is scheduled to be in stock by the end of February. We ask for your continued trust in our brand and invite you to purchase our product once it is back in stock. Please do not hesitate to contact us at [email protected] with any questions or concerns.
CoFounder, BioRebalance LLC